1. Drug Monitoring. The role of the hospital. WHO Technical Report Series 425. World Health Organization, Geneva, Switzerland, 1969.
2. Edwards IR, Biriell C. Harmonization in pharmacovigilance. Drug Saf 1994; 10: 93-102.
3. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996; 16: 701-707.
4. Imbs JL, et al. Iatrogenie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Thérapie 1999; 34: 21-27.
5. Lazarou J, et al. Incidence of adverse drug reactions in hospitalized pazients. JAMA 1998; 279: 1200-1205.
6. Rawlins MD, Thompson JW. Mechanisms of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. IVth ed. Oxford: Oxford University Press, 1991: 18-45.
7. Inman WHW, editor. Monitoring for drug safety. 2nd ed. Lancaster: MTP Press, 1986.
8. Royer RJ. Mechanism of action of adverse drug reactions: an overview. Pharmacoepidemiol Drug Saf 1997; Suppl. 3: S43-S50.
9. Meyboom RHB, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16: 355-365.
10. Dukes MNG, editor. Meyler's side effects of drugs. 13th ed. Amsterdam: Elsevier Science Publishers, 1996.
11. Meyboom RHB, et al. Characteristics of topics in pharmacovigilance in the Netherlands. Clin Drug Invest 1996; 4: 207-219.
12. Strom BL, editor. Pharmacoepidemiology. 2nd ed. Chichester: John Wiley & Sons, 1994.
13. The committee for the assessment of the biometric aspects of controlled trials of hypoglycaemic agents. Special Report. JAMA 1975; 213: 583.
14. Committee of Principle Investigators. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Br Heart J 1978; 40: 1069.
15. Kimura K. WHO Data Base on Counterfeit Pharmaceuticals. World Health Organization, Geneva, 1998.
16. Counterfeit Drugs. Guidelines for the development of measures to combat counterfeit drugs. Department of Essential Drugs and Other Medicines. World Health Organization, Geneva, Switzerland, 1999.
17. Conroy S, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000; 320: 79-82.
18. Phillips DP, et al. Increase in US medication-error deaths between 1983-1993. Lancet 1997; 351: 643-644.
19. Kohn LT, et al. editors. To err is human. Building a safer health system. Committee on Quality of Health Care in America. National Academy Press, Washington DC, 1999.
20. Medawar C. The antidepressant web. Int J Risk Saf Med 1997; 10: 75-127.
21. De Broe ME, Elseviers MM. Analgesic nephropathy. N Engl J Med 1998; 338: 446-452.